Literature DB >> 15639716

The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.

Roy Båtevik1, Ketil Grong, Leidulf Segadal, Lodve Stangeland.   

Abstract

Surgical resection is the treatment of choice for non-advanced lung cancer, but is encumbered with an overall relative poor long time prognosis. The purpose of this study was to examine if long time survival for patients operated for non-small cell lung cancer have changed over a 15 years period. We retrospectively studied hospital records of the 351 patients operated, with the intention to cure, for a primary non-small cell carcinoma (NSCLC) in our department between 1 January 1988 and 31 December 2002. Preoperative clinical variables were noted together with variables allowing staging based on pathological examination. Absolute survival and survival relative to expected was studied for the whole group using uni- and multivariate Cox analyses. Early 30 days mortality was 2.0%. The 5-year absolute and relative survivals for all patients were 46.3% and 52.6%, respectively. After 10 years corresponding values were 32.9% and 44.6%. At the end of the study, the 15-year absolute survival was 27.8% with a relative survival of 46.2%. Univariate analysis revealed that age, gender, nodular stage, tumour size, p-stage, type of resection, time of operation and additional cardiovascular disease at the time of operation significantly influenced survival. Multivariate analysis for all patients revealed that low age, female gender, low nodular stage, and operation late in the study period were significant prognostic factors predicting improved survival. When including a population based age- and gender-adjusted median expected life time for every patient as a predictor for survival, only female gender and low nodular stage were additional significant and independent positive prognostic factors.

Entities:  

Mesh:

Year:  2005        PMID: 15639716     DOI: 10.1016/j.lungcan.2004.08.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  21 in total

1.  Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.

Authors:  Jessica R Glover; Frank O Velez-Cubian; Wei Wei Zhang; Kavian Toosi; Tawee Tanvetyanon; Emily P Ng; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Sex-specific aspects of tumor therapy.

Authors:  Kerstin Borgmann; Ekkehard Dikomey; Cordula Petersen; Petra Feyer; Ulrike Hoeller
Journal:  Radiat Environ Biophys       Date:  2009-02-26       Impact factor: 1.925

3.  Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung CANCER.

Authors:  Zhi-Jie Wang; Tong-Tong An; Tony Mok; Lu Yang; Hua Bai; Jun Zhao; Jian-Chun Duan; Mei-Na Wu; Yu-Yan Wang; Ping-Ping Li; Hong Sun; Ping Yang; Jie Wang
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

4.  Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.

Authors:  Jin Sakamoto; Makoto Sonobe; Masashi Kobayashi; Masashi Ishikawa; Ryutaro Kikuchi; Daisuke Nakajima; Tetsu Yamada; Ei Nakayama; Tsuyoshi Takahashi; Toshihiko Sato; Fengshi Chen; Toru Bando; Hiroshi Date
Journal:  Int J Clin Oncol       Date:  2012-12-14       Impact factor: 3.402

5.  Survival after resection for primary lung cancer: a population based study of 3211 resected patients.

Authors:  T-E Strand; H Rostad; B Møller; J Norstein
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

6.  Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.

Authors:  Fabien Gueugnon; Aurélia Barascu; Konstantinos Mavridis; Agnès Petit-Courty; Sylvain Marchand-Adam; Valérie Gissot; Andreas Scorilas; Serge Guyetant; Yves Courty
Journal:  Tumour Biol       Date:  2015-02-13

7.  Age and gender differences in medicare expenditures and service utilization at the end of life for lung cancer decedents.

Authors:  Lisa R Shugarman; Chloe E Bird; Cynthia R Schuster; Joanne Lynn
Journal:  Womens Health Issues       Date:  2008 May-Jun

8.  Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort.

Authors:  Marshall W Pitz; Grace Musto; Srisala Navaratnam
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

9.  Predicting survival in potentially curable lung cancer patients.

Authors:  Thida Win; Linda Sharples; Ashley M Groves; Andrew J Ritchie; Francis C Wells; Clare M Laroche
Journal:  Lung       Date:  2008-02-09       Impact factor: 2.584

10.  Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients.

Authors:  Rafaela Festugatto Tartari; Jane Maria Ulbrich-Kulczynski; Antônio Fabiano Ferreira Filho
Journal:  Oncol Lett       Date:  2013-01-11       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.